Hendra virus.Vet Clin North Am Equine Pract. 2014 Dec; 30(3):579-89.VC
Abstract
Hendra virus infection of horses occurred sporadically between 1994 and 2010 as a result of spill-over from the viral reservoir in Australian mainland flying-foxes, and occasional onward transmission to people also followed from exposure to affected horses. An unprecedented number of outbreaks were recorded in 2011 leading to heightened community concern. Release of an inactivated subunit vaccine for horses against Hendra virus represents the first commercially available product that is focused on mitigating the impact of a Biosafety Level 4 pathogen. Through preventing the development of acute Hendra virus disease in horses, vaccine use is also expected to reduce the risk of transmission of infection to people.
Links
Pub Type(s)
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Language
eng
PubMed ID
25281398
Citation
Middleton, Deborah. "Hendra Virus." The Veterinary Clinics of North America. Equine Practice, vol. 30, no. 3, 2014, pp. 579-89.
Middleton D. Hendra virus. Vet Clin North Am Equine Pract. 2014;30(3):579-89.
Middleton, D. (2014). Hendra virus. The Veterinary Clinics of North America. Equine Practice, 30(3), 579-89. https://doi.org/10.1016/j.cveq.2014.08.004
Middleton D. Hendra Virus. Vet Clin North Am Equine Pract. 2014;30(3):579-89. PubMed PMID: 25281398.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Hendra virus.
A1 - Middleton,Deborah,
Y1 - 2014/09/30/
PY - 2014/10/5/entrez
PY - 2014/10/5/pubmed
PY - 2015/4/11/medline
KW - Disease
KW - Emerging
KW - Hendra
KW - Horse
KW - Infectious
KW - Pathogenesis
KW - Vaccine
KW - Zoonotic
SP - 579
EP - 89
JF - The Veterinary clinics of North America. Equine practice
JO - Vet Clin North Am Equine Pract
VL - 30
IS - 3
N2 - Hendra virus infection of horses occurred sporadically between 1994 and 2010 as a result of spill-over from the viral reservoir in Australian mainland flying-foxes, and occasional onward transmission to people also followed from exposure to affected horses. An unprecedented number of outbreaks were recorded in 2011 leading to heightened community concern. Release of an inactivated subunit vaccine for horses against Hendra virus represents the first commercially available product that is focused on mitigating the impact of a Biosafety Level 4 pathogen. Through preventing the development of acute Hendra virus disease in horses, vaccine use is also expected to reduce the risk of transmission of infection to people.
SN - 1558-4224
UR - https://www.unboundmedicine.com/medline/citation/25281398/Hendra_virus_
DB - PRIME
DP - Unbound Medicine
ER -
Try the Free App:
